Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Natàlia Picola"'
Autor:
Juan Morote, Nahuel Paesano, Natàlia Picola, Jesús Muñoz-Rodriguez, Xavier Ruiz-Plazas, Marta V. Muñoz-Rivero, Ana Celma, Gemma García-de Manuel, Berta Miró, Pol Servian, José M. Abascal
Publikováno v:
International Brazilian Journal of Urology, Vol 50, Iss 5, Pp 595-604 (2024)
ABSTRACT Purpose: To validate the Barcelona magnetic resonance imaging predictive model (BCN-MRI PM) in men with pre-biopsy multiparametric MRI (mpMRI) reported with the Prostate Imaging Reporting and Data System (PI-RADS) v2.1, followed by transrect
Externí odkaz:
https://doaj.org/article/c9e9c2661ec34b66bbe35b94836acd6b
Autor:
Juan Morote, Nahuel Paesano, Natàlia Picola, Jesús Muñoz-Rodriguez, Xavier Ruiz-Plazas, Marta V. Muñoz-Rivero, Ana Celma, Gemma García-de Manuel, José M. Abascal, Pol Servian
Publikováno v:
European Urology Open Science, Vol 66, Iss , Pp 5-8 (2024)
Quality control of programs for detection of significant prostate cancer (sPCa) could be defined by the correlation between observed and reference 95% confidence intervals (CIs) for Prostate Imaging-Reporting and Data System (PI-RADS) categories. We
Externí odkaz:
https://doaj.org/article/70a95c67d50c4b78846edcbc9b9cf9bf
Autor:
Juan Morote, Natàlia Picola, Jesús Muñoz-Rodriguez, Nahuel Paesano, Xavier Ruiz-Plazas, Marta V. Muñoz-Rivero, Ana Celma, Gemma García-de Manuel, Berta Miró, José M. Abascal, Pol Servian
Publikováno v:
The World Journal of Men's Health, Vol 42, Iss 2, Pp 441-448 (2024)
Purpose: To relate the prostate volume category (PVC) assessed with digital rectal examination (DRE)—small, median, and large—and the prostate volumes (PVs) assessed with magnetic resonance imaging (MRI) and transrectal ultrasound (TRUS). To co
Externí odkaz:
https://doaj.org/article/77655c36076142819ee53f080ed6f91c
Autor:
Juan Morote, Natàlia Picola, Jesús Muñoz-Rodriguez, Nahuel Paesano, Xavier Ruiz-Plazas, Marta V. Muñoz-Rivero, Ana Celma, Gemma García-de Manuel, Berta Miró, Pol Servian, José M. Abascal
Publikováno v:
Biomolecules, Vol 14, Iss 2, p 193 (2024)
Concerns exist regarding the effects of 5-alpha reductase inhibitors (5-ARIs) on multipa-rametric magnetic resonance imaging (mpMRI) and clinically significant prostate cancer (csPCa) detection. Our objective is to analyze the effect of 5-ARI on the
Externí odkaz:
https://doaj.org/article/fa47f7f2bd59455bb28c50b77f3fbe70
Autor:
Juan Morote, Natàlia Picola, Nahuel Paesano, Anna Celma, Jesús Muñoz-Rodriguez, Ignacio Asiain, Xavier Ruiz-Plazas, Marta V. Muñoz-Rivero, Gemma García de Manuel, Pol Servian, José M. Abascal
Publikováno v:
Urologic Oncology: Seminars and Original Investigations.
Autor:
Mario Hassi Roman, Kinga Mate, Pedro De Pablos-Rodriguez, Álvaro Zamora Horcajada, Ana Guijarro Cascales, Ángeles Sanchís Bonet, Antoni Vilaseca, Darío Vázquez-Martul Pazos, Estefanía Linares Espinós, Jesús Muñoz Rodríguez, José Manuel de la Morena Gallego, José Ramón Alemán, Juan Gómez Rivas, Luigi Formisano, Maria J. Juan Fita, Marc Costa Planells, Mario Domínguez Esteban, Meritxell Pérez Márquez, Miguel García Sanz, Nagore García Expósito, Natalia Picola, Pol Servian Vives, Raquel Sopeña Sutil, Miguel A. Climent Durán, Miguel Ramírez Backhaus
Publikováno v:
European Urology Open Science, Vol 70, Iss , Pp 58-63 (2024)
Background and objective: The depth of the prostate-specific antigen (PSA) decline after androgen receptor pathway inhibitor (ARPI) treatment combined with androgen deprivation therapy for patients with metastatic hormone-sensitive prostate cancer (m
Externí odkaz:
https://doaj.org/article/0fc7ebd364174fe89c2487f7f9fb39f3
Autor:
Julián Córdoba Sánchez, Natalia Picola, Alejo Rodriguez‐Vida, Marc Costa, David Marmolejo Castañeda, Meritxell Pérez Márquez, Jesús Muñoz Rodriguez, J. M. Gaya, Alejandra Bravo, Oscar Buisan, Pol Servian, Jose Francisco Suarez, Mireia Musquera Felip, Maria Jose Ribal Caparrós, Antonio Alcaraz Asensio, Antoni Vilaseca
Publikováno v:
Cancer Medicine, Vol 12, Iss 24, Pp 21969-21977 (2023)
Abstract Objective To evaluate the efficacy and safety of apalutamide prostate cancer compared to the pivotal trials patients and to identify the first subsequent therapy in a real‐world setting. Methods The study is prospective and observational b
Externí odkaz:
https://doaj.org/article/80a7c7a4e5bf42c59346f59c54b642d5